METHODS OF TREATING A TUMOR USING AN ANTI-PD-1 ANTIBODY
This disclosure provides a method for treating a subject afflicted with tumor, which method comprises administering to the subject an antibody or an antigen-binding portion thereof that specifically binds to a Programmed Death-1 (PD-1) receptor and inhibits PD-1 activity. In some embodiments, the tu...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
10.01.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This disclosure provides a method for treating a subject afflicted with tumor, which method comprises administering to the subject an antibody or an antigen-binding portion thereof that specifically binds to a Programmed Death-1 (PD-1) receptor and inhibits PD-1 activity. In some embodiments, the tumor is derived from a non-small cell lung cancer (NSCLC). In some embodiments, the tumor expresses Programmed Death Ligand 1. In some embodiments, the subject carries a wild-type STK11 gene.
本公开提供用于治疗患有肿瘤的受试者的方法,该方法包括对受试者施用特异性结合程序性死亡-1(PD-1)受体并抑制PD-1活性的抗体或其抗原结合部分。在一些实施方案中,该肿瘤源自非小细胞肺癌(NSCLC)。在一些实施方案中,该肿瘤表达程序性死亡配体1。在一些实施方案中,该受试者携带野生型STK11基因。 |
---|---|
Bibliography: | Application Number: CN20188035434 |